Shionogi and MPP sign licence agreement for COVID-19 oral antiviral treatment
Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.
Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.
Juan Andres Appointed to President, Strategic Partnerships and Enterprise Expansion
There are certain foods can influence blood pressure, triglycerides, cholesterol levels and inflammation, all of which are risk factors for heart disease.
‘PathoDetect HPV Detection Test’ detects and discriminates the presence of high-risk HPV strains including 16 and 18 which cause most of the cervical cancers.
The companies have also initiated a Phase 1/2/3 study NCT05543616 to evaluate the safety, tolerability, and immunogenicity of different doses
Kokilaben Hospital is also the first hospital in Navi Mumbai to receive the SMART ICU certification
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial
Philips FetView will offer real-time, off cart remote patient management with access to data from any ultrasound system
Subscribe To Our Newsletter & Stay Updated